Hu Meng

This inventor holds 1 USPTO granted patent. Top assignee: Recode Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hu Meng. Retrieved from https://idiyas.com/inventor/hu-meng-ftds4z1g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hu Meng - Innovator in RNA Quantification

Introduction

Hu Meng is a notable inventor recognized for his contributions to the field of molecular biology. He currently works at Recode Therapeutics, Inc., where he focuses on innovative methods for RNA research. His work is pivotal in advancing our understanding of messenger RNA.

Latest Patents

Hu Meng holds a patent titled "Method for Quantifying an Amount of Capped Messenger RNA." This patent represents a significant advancement in the quantification of RNA, which is crucial for various applications in genetic research and therapeutics. He has 1 patent to his name, showcasing his innovative approach to scientific challenges.

Career Highlights

Throughout his career, Hu Meng has demonstrated a commitment to advancing biotechnology. His work at Recode Therapeutics, Inc. has positioned him as a key player in the development of RNA-based therapies. His research contributes to the broader field of genetic engineering and therapeutic development.

Collaborations

Hu Meng collaborates with esteemed colleagues such as Joseph S Cefalu and Daniella Ishimaru. These partnerships enhance the research environment and foster innovation within the company.

Conclusion

In summary, Hu Meng is an influential inventor whose work in RNA quantification is paving the way for future advancements in biotechnology. His contributions are vital to the ongoing evolution of genetic research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…